INVENIA

Device GE HEALTHCARE
Total Payments
$159,349
Transactions
33
Doctors
3
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $75,202 2 0
2017 $84,147 31 3

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $75,202 2 47.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $40,885 22 25.7%
Travel and Lodging $33,875 4 21.3%
Consulting Fee $9,089 3 5.7%
Food and Beverage $297.25 2 0.2%

Payments by Type

General
$84,147
31 transactions
Research
$75,202
2 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
THE ASSESSMENT OF THE ROLE OF AUTOMATED BREAST ULTRASOUND (ABUS) IN SCREENING WOMEN WITH DENSE BREASTS FOR EARLY DETECTION OF BREAST CANCER GE HEALTHCARE $56,000 0
AUTOMATED BREAST ULTRASOUND FOR DIAGNOSTIC EVALUATION GE HEALTHCARE $19,202 0

Top Doctors Receiving Payments for INVENIA

Doctor Specialty Location Total Records
Unknown Boston, MA $75,202 2
, MD Diagnostic Radiology Santa Fe, NM $42,875 16
, M.D Diagnostic Radiology Washington, DC $39,544 13
, MD Diagnostic Radiology New York, NY $1,728 2

About INVENIA

INVENIA is a device associated with $159,349 in payments to 3 healthcare providers, recorded across 33 transactions in the CMS Open Payments database. The primary manufacturer is GE HEALTHCARE.

Payment data is available from 2017 to 2020. In 2020, $75,202 was paid across 2 transactions to 0 doctors.

The most common payment nature for INVENIA is "Unspecified" ($75,202, 47.2% of total).

INVENIA is associated with 2 research studies, including "THE ASSESSMENT OF THE ROLE OF AUTOMATED BREAST ULTRASOUND (ABUS) IN SCREENING WOMEN WITH DENSE BREASTS FOR EARLY DETECTION OF BREAST CANCER" ($56,000).